Prevalence, Characteristics, andRisk Factor of Patient with Peripartum Cardiomyopathyin Hasan Sadikin Hospital Bandung
AbstractBackground. Peripartum cardiomyopathy (PPCM) is one of the important health problem and can be fatal. The aim of this study is to determine the prevalence and characteristics of patients with PPCM in the Hasan Sadikin Hospital (RSHS).
Methods. Data were retrieved retrospectively from medical records at the Cardiology and Vascular Medicine, RSHS, Bandung, from 1stJanuary2011 to 31thDecember, 2013. The analysis was performed using SPSS 21 and Chi Square significance test.
Results.Eighty (26.23%,) subjects with PPCM out of 305 women with pregnancy or postpartum and cardiovascular complications are paticipated. The PPCMproportion are significantly decrease by time from 51.25%, 27.5%, 21,25% in 2011, 2012, and 2013 respectively. The average age was 30.3±7.9years. Deliveries were cesarean delivery in 43.8%, pervaginal in 37.5%, forceps in 15%, and vacuum-extractor in 3.8%. Preeclampsia was found in 43.8% of patients and most of them with NYHA functional class IV (86.3The average ejection fraction of 34.8±7.5%.
Conclusion. The prevalence of PPCM in RSHS is 26.23%, with the majority (86.3%) was NYHA functional class IV.Significant risk factorsof PPCM were age over 30 years, multiparous, low socioeconomic, and preeclampsia.
Sarker HN, Dass BP. Peripartum cardiomyopathy. ORION. 2009;32:686-89.
Rmaraj K,Sorrel VL.Peripartum Cardiomyopathy:Causes, diagnosis,and treatment. Cleve Clin J Med.2009;76(5):289-96.
Aursulesei V,Datcu MD.Peripartum cardiomyopathy: A Systemic Review. Int J Cardiol. 2009;131(2):8-35.
Elkayam U.Clinical characteristics of peripartum cardiomyopathy in the United State. J Am Coll Cardiol. 2011;58(7):659-70.
Zagrosek VR,Lundqvist CB,Borghi C,Cifkova R,Ferreira R,Foidart JM,et al.Guidelines on the management of cardiovascular diseases during pregnancy. Eur Heart J. 2011;32:3147-97.
Joint National Comitte. The seventh report of the Joint Nationl Committe on prevention, detection, evaluation,treatment of high blood pressure.NIH.2004: 30-52.
Walenta K,Schwarz V,Schirmer SH,Kinderman I,Friedrich EB,Solomayer EF,et al.Circulating microparticles as indicators of peripartum cardiomyopathy.Eur Heart J.2012;33:1469-79.
Elkayam U,Mohammed W,Akhter,Singh H, Khan S, Bitar F,et al.Pregnancy-Associated Cardiomyopathy: Clinical characteristics and a comparison between early dan late presentation.Circulation.2005;111: 2050-55.
Sliwa K,Fett J,Elkayam U.Peripartum cardiomyopathy. Lancet.2006;368: 687-93.
Lim CP,Sim DK.Peripartum cardiomyopathy:experience in an Asian tertiary centre.Singapore Med J.2013;54(1):24-27.
Shah I,Hafizullah M,Shah TS,Faheem M,Rafiullah.Peripartum cardiomyopathy: risk factors,hospital course and prognosis; experiences at Lady Reading Hospital Peshawar.GARJPP. 2012;1(1):1-11.
Johnson-Coyle L,Jensen L,Sobey A.Peripartum cardiomyopathy: Review and practice guidelines.Am J Crit Care Med.2012;21(2):89-97.
Goland S,Modi K,Bitar F,Janmohamed M,Mirocha JM,Czer L.Clinical profile and predictors of complications in peripartum cardiomyopathy.J Card Fail.2009;28(5):1-6.
Sliwa K,Blauwet L,Tibazarwa K,Smedema JP,Becker A,Mc Muray J,et al.Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: A proof of concept Pilot Study.Circulation.2010;121:1465-73.
Habedank D,Kuhnle Y,Elgeti T,Dudenhausen JW,Haverkamp W,Dietz R.Recovery from peripartum cardiomyopathy after treatment with bromocriptine.2008;10:1149-51.
Anderson JL,Horne BD.Birthing the genetics of peripartum cardiomyopathy .Circulation.2010;121:2157-59.
Shafiq M,Khan RA,Khan A,Shah A,Hussain S.Unrecognised peripartum cardiomyopathy will have dire consequences.Anest Pain Int Care.2013;17(2):195-7.
Hasan JA,Qureshi A,Ramejo BB,Kamran A.Peripartum cardiomyopathy characteristics and outcome in a tertiary care hospital.J Park Med Assoc.2010;60:377-80.
Shaikh S,ShaikhSA.Peripartum cardiomyopathy:Its frequency and maternal outcome.BJOG.2010;16(4):590-3.
PDF downloads: 2
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).